NeuroNOS is a company focused on developing innovative treatments for Autism Spectrum Disorder (ASD) and other neurological conditions.
NeuroNOS has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in March 2025.
NeuroNOS is headquartered in Boston, United States.
NeuroNOS is a company focused on developing innovative treatments for Autism Spectrum Disorder (ASD) and other neurological conditions.
NeuroNOS is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuroNOS — Funding & Investors." VCBacked, March 24, 2025, https://www.vcbacked.co/company/neuronos. Accessed August 1, 2026.
VCBacked. (2025). NeuroNOS — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/neuronos
{{cite web |title=NeuroNOS — Funding & Investors |url=https://www.vcbacked.co/company/neuronos |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated